Assignment of CDC weak oxidizer group 2 (WO-2) to the genus Pandoraea and characterization of three new Pandoraea genomospecies

Journal of Clinical Microbiology
M I DaneshvarR S Weyant

Abstract

CDC weak oxidizer group 2 (WO-2) consists of nine phenotypically similar human clinical isolates received by the Centers for Disease Control and Prevention between 1989 and 1998. Four of the isolates were from blood, three were from sputum, and one each was from bronchial fluid and maxillary sinus. All are aerobic nonfermentative, motile gram-negative rods with one to eight polar flagella per cell. All grew at 25 and 35 degrees C and were positive for catalase, urease (usually delayed 3 to 7 days), citrate, alkalinization of litmus milk, oxidization of glycerol (weakly), and growth on MacConkey agar and in nutrient broth without NaCl. All except one strain were oxidase positive with the Kovács method, and all except one isolate weakly oxidized D-glucose. All were negative for oxidation of D-xylose, D-mannitol, lactose, sucrose, maltose, and 20 other carbohydrates, esculin hydrolysis, indole production, arginine dihydrolase, and lysine and ornithine decarboxylase. Only two of nine isolates reduced nitrate. Broth microdilution susceptibilities were determined for all strains against 13 antimicrobial agents. Most of the strains were resistant to ampicillin, extended-spectrum cephalosporins, and aminoglycosides, including gentamici...Continue Reading

References

Jan 1, 1991·Journal of Bacteriology·W G WeisburgD J Lane
Jun 1, 1990·Journal of Clinical Microbiology·J A TrotterD F Welch
Dec 5, 1973·Journal of Molecular Biology·T I BonnerR J Britten
Jun 1, 1984·Journal of Clinical Microbiology·C W MossC Patton
Jul 1, 1983·Journal of Clinical Microbiology·C W Moss, G O Guerrant
Jun 1, 1982·Journal of Clinical Microbiology·D J BrennerA G Steigerwalt
Apr 1, 1993·Journal of Clinical Microbiology·J S DalyS P O'Connor
Sep 1, 1994·Computer Applications in the Biosciences : CABIOS·Y Van de Peer, R De Wachter

❮ Previous
Next ❯

Citations

Sep 14, 2004·The Pediatric Infectious Disease Journal·Lindsey N JohnsonJanet A Englund
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·Ines SchneiderAdolf Bauernfeind
Apr 9, 2010·Clinical Microbiology Reviews·John J Lipuma
Nov 29, 2001·Journal of Clinical Microbiology·T CoenyeJ J LiPuma
May 8, 2003·Journal of Clinical Microbiology·Martin E StryjewskiBarbara D Alexander
Mar 14, 2009·The Journal of General and Applied Microbiology·Yu ZhouRen Lai
Oct 23, 2013·Sensors·Robson Ee Han-JenChan Kok-Gan
Feb 5, 2014·The Journal of General and Applied Microbiology·Jian-Hang QuJing-Ping Cai
Sep 14, 2013·Journal of Postgraduate Medicine·A K Dhariwal, M S Tullu
Jul 31, 2007·Future Microbiology·Christopher D SibleyMichael G Surette
Oct 2, 2003·Pediatric Pulmonology·Inger Merete JørgensenChristian Koch
Dec 27, 2015·BMC Infectious Diseases·Nicolas DegandJacqueline Carrère
Nov 14, 2015·Genome Announcements·A D MillardC I Constantinidou
Oct 19, 2010·International Journal of Systematic and Evolutionary Microbiology·Nurettin SahinAbdurrahman U Tamer
Aug 1, 2009·International Journal of Systematic and Evolutionary Microbiology·Rangasamy AnandhamHyeong Jin Jee
Jun 24, 2014·The Science of the Total Environment·Qichun Zhang, Warren A Dick
Jun 1, 2016·Frontiers in Microbiology·Mark AmbroseLouise F Roddam
Jun 9, 2016·International Journal of Systematic and Evolutionary Microbiology·Sang Eun JeongChe Ok Jeon
Jun 12, 2014·Sensors·Robson EeKok-Gan Chan
Sep 10, 2015·Antimicrobial Agents and Chemotherapy·Ines Schneider, Adolf Bauernfeind
Aug 11, 2018·Current Opinion in Pulmonary Medicine·Heather Green, Andrew M Jones
Jan 25, 2019·International Journal of Systematic and Evolutionary Microbiology·Wah Seng See-TooLouise F Roddam
Jan 5, 2019·Molecular Biology and Evolution·George C diCenzoElena Perrin
Oct 4, 2012·Expert Review of Anti-infective Therapy·Silpak BiswasJean-Marc Rolain
Sep 4, 2019·Italian Journal of Pediatrics·Mohammad TabatabaeiMohammad Ashkan Moslehi
Dec 11, 2007·Journal of Medical Microbiology·Emma CaraherSiobhán McClean
Jan 19, 2008·Journal of Medical Microbiology·M Aravena-Román
Apr 6, 2002·FEMS Microbiology Letters·Tom Coenye, John J LiPuma
Nov 30, 2019·Frontiers in Microbiology·Charlotte PeetersPeter Vandamme
Mar 29, 2020·Microbiology Resource Announcements·Miranda E PittLachlan J M Coin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.